Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
- 2 July 1999
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 13 (4), 358-371
- https://doi.org/10.1177/026988119901300405
Abstract
Abnormalities of dopamine function in schizophrenia are suggested by the common antidopaminergic properties of antipsychotic medications. However, direct evidence of a hyperdopaminergic state in schizophrenia has been diffcult to demonstrate, given the diffculty of measuring dopamine transmission in the living human brain. This situation is rapidly changing. Recent developments in positron emission tomography and single-photon emission tomographic techniques enabled measurement of acute fluctuation of synaptic dopamine in the vicinity of D2 receptors. Using this technique, we, and others, measured the increase in dopamine transmission following aute amphetamine challenge in untreated patients with schizophrenia and matched healthy subjects. Following a brief overview of these new brain imaging techniques, the main results derived with this method in patients with schizophrenia are described: (1) amphetamine-induced dopamine release is elevated in patients with schizophrenia, supporting the idea that schizophrenia is associated with dysregulation of dopamine transmission; (2) following amphetamine, hyperactivity of dopamine transmission is associated with activation of psychotic symptomatology; (3) this dysregulation of dopamine release is not a long-term consequence of previous neuroleptic treatment, and is detected in never-medicated patients experiencing a first episode of the illness; and (4) in contrast, this exaggerated response of the dopamine system to amphetamine exposure is not detected in patients studied during a period of illness stabilization, suggesting that the hyperdopaminergic state associated with schizophrenia fluctuates over time. In conclusion, a hyperdopaminergic state might be present in schizophrenia during the initial episode and subsequent relapses, but not during periods of remission. This finding has important consequences for the development of new treatment strategies for the remission phase.Keywords
This publication has 101 references indexed in Scilit:
- Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]IomazenilAmerican Journal of Psychiatry, 1998
- Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approachSynapse, 1998
- Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography methodProceedings of the National Academy of Sciences, 1997
- Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervationBrain Research, 1996
- Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine — an in vivo dialysis study in freely moving ratsBrain Research, 1990
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- CNS stimulants as tools in the study of schizophreniaTrends in Neurosciences, 1984
- Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjectsPsychopharmacology, 1980
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963